Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
Monovalent XBB.1.5 vaccine had a moderate protective effect against severe and fatal COVID-19 likely caused by BA.2.86/JN.1 during the 2023/2024 winter, among persons aged ≥65.
Authors
- James Humphreys
- Toon Braeye (ORCID: https://orcid.org/0000-0002-5637-4613)
- Jesús Castilla
- Ida Rask Moustsen‐Helms (ORCID: https://orcid.org/0000-0002-1143-511X)
- Susana Monge (ORCID: https://orcid.org/0000-0003-1412-3012)
- Hinta Meijerink (ORCID: https://orcid.org/0000-0002-5898-2778)
- Nicklas Pihlström (ORCID: https://orcid.org/0000-0001-6812-0971)
- Carla Nunes (ORCID: https://orcid.org/0000-0003-4562-1057)
- Izaak Van Evercooren
- Massimo Fabiani (ORCID: https://orcid.org/0000-0002-5893-7117)
- Sabrina Bacci (ORCID: https://orcid.org/0000-0002-6575-3439)
- Ausenda Machado (ORCID: https://orcid.org/0000-0002-1849-1499)
- Nathalie Nicolay (ORCID: https://orcid.org/0000-0002-5916-7855)
- Chiara Sacco (ORCID: https://orcid.org/0000-0002-3958-8353)
- Christian Holm Hansen (ORCID: https://orcid.org/0000-0002-5949-0097)
- Anthony Nardone (ORCID: https://orcid.org/0000-0003-1138-0937)
- Patrícia Soares (ORCID: https://orcid.org/0000-0001-5033-9115)
- Rickard Ljung (ORCID: https://orcid.org/0000-0002-0654-4530)
- Iván Martínez‐Baz (ORCID: https://orcid.org/0000-0002-3405-2277)
Institutions
- Statens Serum Institut (DK)
- Medical Products Agency (SE)
- Norwegian Institute of Public Health (NO)
- Istituto Superiore di Sanità (IT)
- Instituto de Salud Carlos III (ES)
- Ricardo (United Kingdom) (GB)
- Instituto de Salud Pública de Navarra (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Instituto Nacional de Saúde (MZ)
- National Institute of Health Dr. Ricardo Jorge (PT)
- Sciensano (Belgium) (BE)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1080/14760584.2024.2428800
- Citations
- 21
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 12.03